#drug resistance — Thursday, October 01, 2026 (1 items)
| 3 | ℹ |
Giredestrant plus Everolimus in Advanced Breast Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-10-01 | #breast cancer #clinical trial #endocrine therapy #estrogen receptor #drug resistance |